Literature DB >> 12080123

Biophysical characterization of triacyl monosaccharide lipid a partial structures in relation to bioactivity.

Klaus Brandenburg1, Motohiro Matsuura, Holger Heine, Mareike Müller, Makato Kiso, Hideharu Ishida, Michel H J Koch, Ulrich Seydel.   

Abstract

Synthetic triacyl glucosamine monosaccharide lipid A part structures corresponding to the non-reducing moiety of enterobacterial lipid A with an acyloxyacyl chain linked to position 3 of the glucosamine and an unbranched chain linked to position 2 (group 1) and vice versa (group 2) were analyzed biophysically: Fourier-transform infrared spectroscopy was performed to characterize the gel-to-liquid crystalline phase transition, the phosphate band contour, and the orientation of the glucosamine with respect to the membrane surface. Small-angle x-ray diffraction was applied for the elucidation of the supramolecular aggregate structure and, with that, of the molecular shape. With fluorescence resonance energy transfer the lipopolysaccharide-binding protein (LBP)-mediated intercalation of the lipid A partial structures into phospholipid liposomes was monitored. The physical data clearly exhibit a classification of the synthetic compounds into two groups: group 1 compounds have sharp phase transitions, indicating dense acyl chain packing and an inclination of the glucosamine backbone with respect to the membrane surface of 30 degrees with the phosphate buried in the membrane. Group 2 compounds have a very broad phase transition, indicating poorly packed acyl chains, and an inclination of -30 degrees with the phosphate group sticking outward. For the first group unilamellar phases are observed superimposed by a non-lamellar structure, and for the second one only multilamellar aggregate structures. The cytokine-inducing capacity in human mononuclear cells is relatively high for the first group and low or absent for the second group. Based on these data a model of the intra and intermolecular conformations is proposed which also extends the concept of "endotoxic conformation."

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12080123      PMCID: PMC1302150          DOI: 10.1016/S0006-3495(02)75172-2

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

1.  A CD14-independent LPS receptor cluster.

Authors:  K Triantafilou; M Triantafilou; R L Dedrick
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Phase diagram of lipid A from Salmonella minnesota and Escherichia coli rough mutant lipopolysaccharide.

Authors:  K Brandenburg; M H Koch; U Seydel
Journal:  J Struct Biol       Date:  1990 Oct-Dec       Impact factor: 2.867

3.  Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4.

Authors:  J H Krauss; U Seydel; J Weckesser; H Mayer
Journal:  Eur J Biochem       Date:  1989-04-01

Review 4.  Phospholipid phase transitions in model and biological membranes as studied by infrared spectroscopy.

Authors:  H H Mantsch; R N McElhaney
Journal:  Chem Phys Lipids       Date:  1991-03       Impact factor: 3.329

5.  Synthesis of the optically active 4-O-phosphono-D-glucosamine derivatives related to the nonreducing-sugar subunit of bacterial lipid A.

Authors:  M Kiso; S Tanaka; M Fujita; Y Fujishima; Y Ogawa; H Ishida; A Hasegawa
Journal:  Carbohydr Res       Date:  1987-04-15       Impact factor: 2.104

6.  Structural requirements of lipid A species in activation of clotting enzymes from the horseshoe crab, and the human complement cascade.

Authors:  H Takada; S Kotani; S Tanaka; T Ogawa; I Takahashi; M Tsujimoto; T Komuro; T Shiba; S Kusumoto; N Kusunose
Journal:  Eur J Biochem       Date:  1988-08-15

7.  Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS.

Authors:  J C Mathison; P S Tobias; E Wolfson; R J Ulevitch
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

8.  Enhancement of nonspecific resistance to bacterial infections and tumor regressions by treatment with synthetic lipid A-subunit analogs. Critical role of N- and 3-O-linked acyl groups in 4-O-phosphono-D-glucosamine derivatives.

Authors:  M Nakatsuka; Y Kumazawa; M Matsuura; J Y Homma; M Kiso; A Hasegawa
Journal:  Int J Immunopharmacol       Date:  1989

9.  Induction of human interleukin 1 by bacterial and synthetic lipid A.

Authors:  H Loppnow; L Brade; H Brade; E T Rietschel; S Kusumoto; T Shiba; H D Flad
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

10.  Non-specific protective activity of synthetic lipid A-subunit analogs against microbial infections is influenced by their 2-N- and 3-O-linked acyl substituents in the D-glucosamine backbone.

Authors:  S Ikeda; M Matsuura; M Nakatsuka; J Y Homma; M Kiso; A Hasegawa; C Nishimura
Journal:  J Clin Lab Immunol       Date:  1990-08
View more
  4 in total

1.  Thermodynamic analysis of the lipopolysaccharide-dependent resistance of gram-negative bacteria against polymyxin B.

Authors:  Jörg Howe; Jörg Andrä; Raquel Conde; Maite Iriarte; Patrick Garidel; Michel H J Koch; Thomas Gutsmann; Ignacio Moriyón; Klaus Brandenburg
Journal:  Biophys J       Date:  2007-01-19       Impact factor: 4.033

2.  Toll-like receptor activation of human cells by synthetic triacylated lipid A-like molecules.

Authors:  Irène Dunn-Siegrist; Pierre Tissières; Geneviève Drifte; Jacques Bauer; Stéphane Moutel; Jérôme Pugin
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

3.  Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approach.

Authors:  Jace W Jones; Scott A Shaffer; Robert K Ernst; David R Goodlett; Frantisek Turecek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

4.  Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses.

Authors:  Martha Triantafilou; Klaus Brandenburg; Shoichi Kusumoto; Koichi Fukase; Alan Mackie; Ulrich Seydel; Kathy Triantafilou
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.